137 related articles for article (PubMed ID: 8268974)
1. Relationship of IL-2, IL-2R (CD25+), soluble IL-2R and IL-4 with disease activity in SLE patients.
Cuadrado MJ; Marubayashi M; Ortega C; Fernandez-Arcas N; Garcia-Cozar F; Pena J; Sanchez-Guijo P; Santamaria M
Lupus; 1993 Aug; 2(4):257-60. PubMed ID: 8268974
[TBL] [Abstract][Full Text] [Related]
2. Soluble interleukin 2 receptor levels in serum and its relationship to T cell abnormality and clinical manifestations of the disease in patients with systemic lupus erythematosus.
Raziuddin S; al-Janadi MA; al-Wabel AA
J Rheumatol; 1991 Jun; 18(6):831-6. PubMed ID: 1680190
[TBL] [Abstract][Full Text] [Related]
3. Increased soluble IL-2 receptor in serum of patients with systemic lupus erythematosus.
Sawada S; Hashimoto H; Iijma S; Tokano Y; Matsukawa Y; Takei M; Ishikawa H; Kang H; Tomura K; Mitamura K
Clin Rheumatol; 1993 Jun; 12(2):204-9. PubMed ID: 8358979
[TBL] [Abstract][Full Text] [Related]
4. Expression of IL-2R, IL-4R, IL-6R on peripheral blood lymphocytes in systemic lupus erythematosus and correlation with disease activity: a prospective study.
Chan EY; Lau CS; Zola H
J Clin Pathol; 1996 Aug; 49(8):660-3. PubMed ID: 8881918
[TBL] [Abstract][Full Text] [Related]
5. Impaired urinary excretion of soluble IL-2 receptors in patients with systemic lupus erythematosus and rheumatoid arthritis.
Manoussakis MN; Germanidis GS; Drosos AA; Moutsopoulos HM
Lupus; 1992 Feb; 1(2):105-9. PubMed ID: 1301961
[TBL] [Abstract][Full Text] [Related]
6. Relation between soluble interleukin 2 receptor and clinical findings in patients with systemic lupus erythematosus.
Tokano Y; Murashima A; Takasaki Y; Hashimoto H; Okumura K; Hirose S
Ann Rheum Dis; 1989 Oct; 48(10):803-9. PubMed ID: 2818016
[TBL] [Abstract][Full Text] [Related]
7. Serum interleukin-2 receptor in systemic lupus erythematosus and rheumatoid arthritis.
Lee GL; Chen MY; Chuang CY; Chen CY
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1988 Feb; 21(1):16-22. PubMed ID: 3264781
[TBL] [Abstract][Full Text] [Related]
8. Lack of association between hyperprolactinemia and soluble IL-2 receptor levels in systemic lupus erythematosus.
Daza L; Lavalle C; Duarte C; Huerta R; Moreno J
Lupus; 2003; 12(2):107-11. PubMed ID: 12630754
[TBL] [Abstract][Full Text] [Related]
9. The relationship between soluble interleukin 2 receptor levels and antidouble stranded DNA antibody levels in patients with systemic lupus erythematosus.
Ward MM; Dooley MA; Christenson VD; Pisetsky DS
J Rheumatol; 1991 Feb; 18(2):235-40. PubMed ID: 2023217
[TBL] [Abstract][Full Text] [Related]
10. Changes in plasma levels of interleukin-2 receptor in relation to disease exacerbations and levels of anti-dsDNA and complement in systemic lupus erythematosus.
ter Borg EJ; Horst G; Limburg PC; Kallenberg CG
Clin Exp Immunol; 1990 Oct; 82(1):21-6. PubMed ID: 2208793
[TBL] [Abstract][Full Text] [Related]
11. Soluble CD23 and interleukin-4 levels in autoimmune chronic active hepatitis and systemic lupus erythematosus.
al-Janadi M; al-Wabel A; Raziuddin S
Clin Immunol Immunopathol; 1994 Apr; 71(1):33-7. PubMed ID: 8137557
[TBL] [Abstract][Full Text] [Related]
12. Changes in levels of soluble T-cell activation markers, sIL-2R, sCD4 and sCD8, in relation to disease exacerbations in patients with systemic lupus erythematosus: a prospective study.
Spronk PE; ter Borg EJ; Huitema MG; Limburg PC; Kallenberg CG
Ann Rheum Dis; 1994 Apr; 53(4):235-9. PubMed ID: 8203951
[TBL] [Abstract][Full Text] [Related]
13. [Serum soluble interleukin 2 receptor levels in patients with diffuse connective tissue diseases].
Sun HY; Liu WL; Xiu HZ
Zhonghua Nei Ke Za Zhi; 1993 Aug; 32(8):528-30. PubMed ID: 8269781
[TBL] [Abstract][Full Text] [Related]
14. [Neopterin and a soluble interleukin-2 receptor in patients with systemic lupus erythematodes].
Horák P; Hermanová Z; Ordeltová M; Faltýnek L; Kusá L; Budíková M; Vavrdová V; Opíchalová D; Ciferská H; Scudla V
Vnitr Lek; 2004 Jun; 50(6):422-7. PubMed ID: 15346634
[TBL] [Abstract][Full Text] [Related]
15. Soluble interleukin-2 receptors in systemic lupus erythematosus.
Wolf RE; Brelsford WG
Arthritis Rheum; 1988 Jun; 31(6):729-35. PubMed ID: 3132927
[TBL] [Abstract][Full Text] [Related]
16. Correlation of serum interleukin-8 and cell surface lysosome-associated membrane protein expression with clinical disease activity in systemic lupus erythematosus.
Holcombe RF; Baethge BA; Wolf RE; Betzing KW; Stewart RM; Hall VC; Fukuda M
Lupus; 1994 Apr; 3(2):97-102. PubMed ID: 7920621
[TBL] [Abstract][Full Text] [Related]
17. Serum soluble IL-2 receptor as a marker of lymphocyte activation in some autoimmune diseases. Effect of immunosuppressive therapy.
Dejica D
Roum Arch Microbiol Immunol; 2001; 60(3):183-201. PubMed ID: 12165973
[TBL] [Abstract][Full Text] [Related]
18. Activation of T lymphocytes in dengue virus infections. High levels of soluble interleukin 2 receptor, soluble CD4, soluble CD8, interleukin 2, and interferon-gamma in sera of children with dengue.
Kurane I; Innis BL; Nimmannitya S; Nisalak A; Meager A; Janus J; Ennis FA
J Clin Invest; 1991 Nov; 88(5):1473-80. PubMed ID: 1939640
[TBL] [Abstract][Full Text] [Related]
19. [Soluble interleukin 2 receptor as activity parameter in serum of systemic and discoid lupus erythematosus].
Blum C; Zillikens D; Tony HP; Hartmann AA; Burg G
Hautarzt; 1993 May; 44(5):290-5. PubMed ID: 8320115
[TBL] [Abstract][Full Text] [Related]
20. Correlation of serum tumor necrosis factor-alpha, interleukin-4 and soluble interleukin-2 receptor levels with radiologic and clinical manifestations in active pulmonary tuberculosis.
Kart L; Buyukoglan H; Tekin IO; Altin R; Senturk Z; Gulmez I; Demir R; Ozesmi M
Mediators Inflamm; 2003 Feb; 12(1):9-14. PubMed ID: 12745543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
